Quercitrin

Quercitrin

SCHEMBL117644

C[C@H]1OC(Oc2c(-c3ccc(O)c(O)c3)oc3cc(O)cc(O)c3c2=O)[C@@H](O)[C@@H](O)[C@@H]1O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P4HB P07237 7/20 1.00
KDM4E B2RXH2 6/20 1.00
L3MBTL1 Q9Y468 4/20 1.00
MAOA P21397 4/20 1.00
EPHX2 P34913 4/20 1.00
XDH P47989 4/20 1.00
SLCO2B1 O94956 4/20 1.00
AKR1B1 P15121 3/20 1.00
PIM2 Q9P1W9 2/20 1.00
ALDH1A1 P00352 2/20 1.00
CA12 O43570 2/20 1.00
CA2 P00918 2/20 1.00
CA4 P22748 2/20 1.00
CA7 P43166 2/20 1.00
NQO2 P16083 1/20 0.85
MAPT P10636 5/20 0.84
POLB P06746 4/20 0.84
GAA P10253 4/20 0.84
KDM1A O60341 2/20 0.84
HMGB1 P09429 2/20 0.84

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Quercitrin SCHEMBL29454400 1.00 P4HB (1.00) P4HBKDM4EL3MBTL1MAOAEPHX2
Quercitrin SCHEMBL5456136 1.00 P4HB (1.00) P4HBKDM4EL3MBTL1MAOAEPHX2
Quercitrin SCHEMBL4227921 1.00 P4HB (1.00) P4HBKDM4EL3MBTL1MAOAEPHX2
Quercitrin SCHEMBL17628907 1.00 P4HB (1.00) P4HBKDM4EL3MBTL1MAOAEPHX2
Quercitrin SCHEMBL811472 1.00 P4HB (1.00) P4HBKDM4EL3MBTL1MAOAEPHX2
Quercitrin SCHEMBL6849807 1.00 P4HB (1.00) P4HBKDM4EL3MBTL1MAOAEPHX2
Quercitrin SCHEMBL15337986 1.00 P4HB (1.00) P4HBKDM4EL3MBTL1MAOAEPHX2
Quercitrin SCHEMBL3206092 1.00 P4HB (1.00) P4HBKDM4EL3MBTL1MAOAEPHX2
Quercitrin SCHEMBL1697151 1.00 P4HB (1.00) P4HBKDM4EL3MBTL1MAOAEPHX2
Quercitrin SCHEMBL29381705 1.00 P4HB (1.00) P4HBKDM4EL3MBTL1MAOAEPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 792 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250386844-A1 HEALTHY SWEETENERS COMPRISING ANTIOXIDANTS Apple Sugar LLC (US) 2025-12-25 US claimed
US-20250319058-A1 COMPOSITIONS AND METHODS USING A COMBINATION OF FISETIN AND QUERCETIN FOR CELLULAR ENERGY NESTLE SA (CH) 2025-10-16 US claimed
US-20250312307-A1 COMPOSITIONS AND METHODS USING A COMBINATION OF FISETIN AND QUERCETIN FOR USE IN CARTILAGE DEGENERATION NESTLE SA (CH) 2025-10-09 US claimed
US-12233101-B2 Compositions and methods useful in treatment of lower urinary tract symptoms, benign prostatic hyperplasia, erectile dysfunction, and other diseases or symptoms NATUREX INC. (US) 2025-02-25 US claimed
US-12163004-B2 Polymer composites WARNER BABCOCK INSTITUTE FOR GREEN CHEMISTRY, LLC (US) 2024-12-10 US claimed
CN-119095594-A Compositions and methods for cartilage degradation using a combination of fisetin and quercetin 雀巢产品有限公司 2024-12-06 CN claimed
CN-119072309-A Compositions and methods for using a combination of neisseria and quercetin for cellular energy 雀巢产品有限公司 2024-12-03 CN claimed
CN-118614566-A Cedrela sinensis phenol-protein gel and preparation method thereof 南京农业大学 2024-09-10 CN claimed
CN-118103046-A Methods and compositions for treating viral infections in animals 菲尼克斯生物技术公司 2024-05-28 CN claimed
CN-118042938-A A method for treating cancer 天然成分与健康研究组织 2024-05-14 CN claimed
CN-102093459-A Penthorum chinense pursh extract and preparation method and application thereof UNIV PLA 2ND MILITARY MEDICAL 2011-06-15 CN claimed
WO-2011044587-A2 CYTOPROTECTIVE OR THERAPEUTIC PLANT COMPOSITION OREGON HEALTH & SCIENCE UNIVERSITY (US) 2011-04-14 WO claimed
EP-2238968-A2 Skin treatment fighting skin aging Henkel AG & Co. KGaA (DE) 2010-10-13 EP claimed
CN-101637484-A Active extract for sanwei sandalwood as well as extraction method and medical application thereof UNIV QINGHAI 2010-02-03 CN claimed
EP-1927378-A1 Hair-treatment compositions comprising quercetin and use thereof to revitalize hair Henkel Kommanditgesellschaft auf Aktien (DE) 2008-06-04 EP claimed
CN-1301722-C Sow thistle extract, preparing process and application thereof SHANGHAI WENDA BIOTECH INC (CN) 2007-02-28 CN claimed
CN-1669572-A Sow thistle extract, preparing process and application thereof SHANGHAI WENDA BIOTECH INC (CN) 2005-09-21 CN claimed
US-6872771-B1 Tire with rubber containing flavone THE GOODYEAR TIRE & RUBBER COMPANY (US) 2005-03-29 US claimed
EP-0275005-B1 COMPLEX COMPOUNDS OF BIOFLAVONOIDS WITH PHOSPHOLIPIDS, THEIR PREPARATION AND USE, AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM INDENA S.p.A. (IT) 1993-08-11 EP claimed
US-4617293-A Flavonoid phosphate salts of aminoglycoside antibiotics MERCK PATENT GESELLSCHAFT MIT BESCHRAENKTER HAFTUNG (DE) 1986-10-14 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250386844-A1 HEALTHY SWEETENERS COMPRISING ANTIOXIDANTS GCK, HK2, GCG P4HB 2389/4885KDM4E 3034/4885L3MBTL1 973/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.